Learn how leading biopharmaceutical manufacturers are transforming downstream processing using Process Analytical Technology (PAT), continuous manufacturing and digital innovation to improve efficiency, product quality and regulatory compliance. Join industry experts for practical insights into the future of biologics production in 2026 and beyond.
As demand for protein-based therapeutics continues to grow, manufacturers face increasing pressure to deliver safe, high-quality biologics faster and more cost-effectively. This creates significant challenges in downstream processing, where efficiency, consistency and regulatory compliance must be balanced.
Traditional batch-based approaches are often time-consuming and resource intensive, prompting the industry to adopt more advanced, data-driven and continuous manufacturing strategies.
Why attend this webinar?
This virtual panel brings together industry experts to discuss practical approaches to improving downstream bioprocessing performance. You’ll hear how organisations are applying advanced technologies to optimise workflows, improve control strategies and support next-generation manufacturing models.
The discussion will also explore how evolving regulatory expectations are shaping adoption of these innovations, and what to expect across the bioprocessing landscape in 2026.
Key topics covered
- How continuous manufacturing is reshaping downstream bioprocessing
- Practical strategies to improve product quality, safety and process efficiency
- Emerging innovations driving change in biologics manufacturing
- Common challenges in monitoring and process control—and how to address them
- The role of analytical testing in material qualification and ongoing process monitoring
- How real-time process insights can improve yield, consistency and reduce variability
What you will learn
By attending this webinar, you will gain practical insight into:
- Implementing Process Analytical Technology (PAT) in downstream workflows
- Improving efficiency, yield and consistency in biologics production
- Leveraging data-driven approaches for better process control and decision-making
- Understanding regulatory considerations for advanced manufacturing systems
- Supporting real-time release (RTR) strategies through improved monitoring and analytics
- Preparing for emerging innovations shaping the future of bioprocessing
Who should attend
This webinar is relevant for professionals working in:
- Bioprocess development and manufacturing
- Analytical sciences and process analytics
- Quality assurance and quality control
- Regulatory affairs and compliance
- Manufacturing science and technology (MSAT)
As biopharmaceutical manufacturing continues to evolve, organisations that embrace data-driven, continuous and digitally enabled approaches will be better positioned to improve efficiency, ensure compliance and accelerate time to market.
Register now to hear practical insights from industry experts and explore the technologies shaping the future of downstream bioprocessing >>
Is the panel discussion free?
Yes – there is no charge to watch the panel discussion, either live or on-demand.
When will the panel discussion take place?
30th July at 3PM BST
Can I watch it later?
The panel discussion will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.
How long will the panel discussion be?
This panel discussion will last up to an hour.
What do I need to watch this panel discussion?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
Enhancing downstream processing for biologic therapies
